Skip to main content

Welkom bij St. Antonius Academie & Bohn Stafleu van Loghum

St. Antonius Academie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met René Schuwer.

Registreer

Om ook buiten de locaties van St. Antonius Academie, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet u zich eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van St. Antonius Academie.

Eenmaal geregistreerd kunt u thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top

Open Access 17-03-2025 | Original Article

Mediators and Predictors of Treatment Response in a Brief Online Intervention for Rumination and Worry

Auteurs: Emily Upton, Venkatesha Venkatesha, Amy E. Joubert, Alison E. J. Mahoney, Michelle L. Moulds, Aliza Werner-Seidler, Jill M. Newby

Gepubliceerd in: Cognitive Therapy and Research

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN

Abstract

Background

Repetitive Negative Thinking (RNT) is a key transdiagnostic mechanism underlying anxiety and depressive disorders, and targeting RNT specifically leads to improved treatment outcomes. There is a lack of research however into mechanisms of change in RNT-focused interventions and factors that predict treatment response. The aim of this study was to examine the mediators and predictors of outcome (RNT, depression, anxiety, and distress) in a brief online intervention for RNT in adults.

Methods

This study used secondary data from a Randomised Controlled Trial of the Managing Rumination and Worry Program (Joubert et al. in Beh Res Therapy, 168:104378, 2023) in which N = 137 adults with elevated levels of RNT were randomly allocated to a 3-lesson clinician-guided or self-guided version of the program delivered over 6 weeks, or a treatment-as-usual (TAU) control condition. Self-report measures of depression, anxiety, distress, and RNT were administered at baseline, post-treatment, and 3-month follow-up; RNT and distress were also measured prior to each lesson.

Results

Intention-to-treat linear mixed models showed a gradual reduction in RNT and distress over treatment in both active conditions, with the largest reductions in RNT occurring after the lessons containing the active treatment strategies (2 and 3). Structural equation modelling mediation analyses showed that reductions in transdiagnostic RNT mediated reductions in distress between Lessons 2 and 3, and reductions in rumination specifically mediated reductions in distress and depression between post-treatment and follow-up, but there was no consistent pattern of mediation by RNT throughout treatment. Finally, higher baseline symptom severity (particularly rumination) significantly predicted poorer post-treatment outcomes, while higher treatment expectancy and clinician guidance significantly predicted better post-treatment outcomes.

Conclusion

This is one of the first studies to examine mediators and predictors of change in a brief, online RNT-focused intervention for adults with elevated RNT. Further research in larger samples is needed, examining additional possible mediating and predictor variables and across more time points, to better understand how and for whom this intervention reduces RNT, anxiety and depression.
Australian and New Zealand Clinical Trials Registration number: ACTRN 12620000959976. Date of registration: 25/09/2020.
Opmerkingen

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Depression and anxiety disorders are among the most prevalent mental illnesses contributing substantially to the global burden of disease (Santomauro et al., 2021), underscoring the key need for more accessible treatment. Repetitive Negative Thinking (RNT) is a key causal and maintaining process across multiple depressive and anxiety disorders (Ehring & Watkins, 2008). RNT encapsulates the process of perseverative and unhelpful thinking in both rumination (repeated abstract, negative thinking about symptoms, causes, meanings, and past events, frequently seen in depression) and worry (repeated catastrophic thinking about potential negative future events, typically characteristic of anxiety; Watkins, 2004). There is evidence that RNT is frequently involved in the onset, maintenance and severity of depressive and anxiety disorders, and the risk of relapse (Ehring & Watkins, 2008; Wahl et al., 2019), and that individuals with higher levels of baseline RNT respond more poorly to cognitive behavioural therapy (CBT) interventions for depression and anxiety (Crane & Williams, 2010; Schmaling et al., 2002). RNT therefore is an important transdiagnostic target for intervention.
Researchers have therefore developed psychological treatments specifically targeting RNT, with evidence that targeting RNT explicitly leads to improved overall treatment outcomes compared to CBT treatments for depression and anxiety that do not specifically address RNT (Spinhoven et al., 2018; Watkins, 2015; Watkins & Roberts, 2020; Watkins, 2022). Rumination-Focused CBT (RF-CBT; Watkins, 2018), for example, was developed to specifically target depressive rumination in the context of depression. RF-CBT significantly reduces worry, rumination, and depression and anxiety symptoms, compared to treatment as usual (Hvenegaard et al., 2020; Teismann et al., 2014; Topper et al., 2017), including in samples of patients with chronic and/or treatment-resistant depression (Watkins et al., 2011). Moreover, RF-CBT reduces the risk of relapse in adolescents and adults with a history of depression (Jacobs et al., 2016), and prevents the development of anxiety and depressive disorders in adolescents and young adults who are at-risk owing to high trait levels of RNT (Cook et al., 2019; Topper et al., 2017).
While there is a growing evidence base demonstrating the effectiveness of RNT-focused interventions, more research is needed to investigate proposed mechanisms of change in these treatments (Ehring, 2021; Watkins, 2009). Specifically, there is a lack of research investigating how RNT-focused treatments work, including whether they successfully alleviate (or prevent) depression or anxiety through changing RNT, and whether changes in RNT precede changes in symptoms (Watkins, 2009). In one trial of RF-CBT (Watkins et al., 2011), decreases in rumination mediated treatment effects on depression symptom severity. More research is needed to replicate these findings, and to extend them by studying the potential mediating effect of changes in RNT on anxiety as well as depression symptoms. Another recent trial which tested whether RF-CBT could prevent depression and Generalised Anxiety Disorder (GAD) in high-risk adolescents (Topper et al., 2017) found that the benefits of the treatment (operationalised as lower prevalence of depression and GAD relative to the control condition) were mediated by changes in RNT during treatment. It is important to examine whether this same pattern of mediation found in prevention studies is observed in currently anxious or depressed individuals in treatment studies.
It is also unknown for whom RNT-focused interventions are most effective, due to the lack of research investigating the factors that predict treatment outcomes in these interventions. Only two identified trials of RNT-focused treatments have each investigated a potential predictor variable. The first (Cook et al., 2019) was a trial of online RF-CBT for the prevention of depression in undergraduate students with high levels of RNT. As hypothesised, due to the interaction between rumination and stressful life events, treatment was more likely to prevent the onset of depression in participants who reported moderate or severe stressful life events at baseline (Cook et al., 2019). The second was a recent study of group-delivered RF-CBT (Wallsten et al., 2023). Despite previous literature showing that patients with higher ratings of treatment credibility and effectiveness prior to commencement (i.e., treatment expectancy) generally experience better outcomes in various psychological therapies (Tambling, 2012), Wallsten et al. (2023) found participants’ ratings of treatment expectancy were not correlated with changes in depression or anxiety symptoms over treatment. To our knowledge, no other studies have investigated potential predictive factors beyond baseline stressful life events or treatment expectancy. In non-RNT-focused CBT interventions for depression and anxiety, participants with higher baseline depression and anxiety severity, and higher baseline rumination and worry, show better treatment response to non RNT-focused CBT interventions (Barrio-Martínez et al., 2023; Karyotaki et al., 2021; Niles et al., 2021; Reins et al., 2021). Further research is needed to examine who is most likely to benefit from RNT-focused treatments and explore how they work, in order to target treatments to appropriate populations, and further enhance their efficacy.

The Current Intervention

There is also evidence that adapting treatments to be brief, and delivered online, can increase their accessibility and uptake while maintaining their effectiveness (Andersson & Carlbring, 2017; Bisby et al., 2024; Ebert et al., 2018; Ruiz et al., 2020). Joubert et al (2021) developed a brief, three-lesson online intervention that specifically targets RNT (Joubert et al., 2021) using principles guided from multiple treatment frameworks including RF-CBT (Watkins, 2018), mindfulness-based cognitive therapy (MBCT; Segal, 2018) and concreteness training (Watkins et al., 2012). The Managing Rumination and Worry Program was developed based on the needs and treatment preferences of individuals with high RNT (Joubert et al., 2022). It was designed to be transdiagnostic in scope, for both clinical and sub-clinical populations who demonstrate high trait levels of RNT, are at risk of developing depression or anxiety, have current symptoms, or are vulnerable to relapse.
The Managing Rumination and Worry Program has been evaluated in a pilot trial (Joubert et al., 2021) and randomised controlled trial (RCT) (Joubert et al., 2023) which showed it was acceptable to participants, and efficacious in reducing the frequency of RNT, as well as symptoms of anxiety, depression, and distress, compared to treatment as usual, both immediately post-treatment and at 3-month follow-up (Joubert et al., 2023). The current study extended their research by exploring the mechanisms of change and factors that predict benefit from this brief online intervention.

Study Aims and Hypotheses

The overall aim of this study was to investigate mediators and predictors of change in depression, anxiety and distress outcomes in the Managing Rumination and Worry Program. Psychological distress was included as an outcome as it is a transdiagnostic variable highly correlated with diagnosis and severity of anxiety and depressive disorders (Andrews & Slade, 2001), and brief to measure (using the Kessler Psychological Distress Scale–10; K-10; Kessler et al., 2002), so it was administered at more frequent timepoints during treatment (prior to each lesson as well as at pre, post, and follow-up). A brief transdiagnostic measure of RNT (the Repetitive Thinking Questionnaire 10-item; RTQ-10; McEvoy et al., 2010) was also administered prior to each lesson, enabling more comprehensive analysis of change in this variable across treatment in addition to pre-to-post change.
1)
Pattern of symptom change across treatment. Firstly, we wanted to understand how RNT and distress changed across each session of treatment, to explore whether there were larger improvements after particular sessions, as a first step towards identifying the most beneficial treatment components. While there is no data to our knowledge on patterns of symptom change in RNT-focused interventions, studies of general CBT for depression and anxiety show varied patterns of symptom improvement in patients who respond well to treatment, including sudden gains after the first session or a gradual improvement over time (Andrews et al., 2020; Bisby et al., 2023; Robinson et al., 2020; Skelton et al., 2023). Thus, these questions were exploratory.
 
2)
Mediating effect of RNT. Secondly, we aimed to investigate whether changes in RNT mediated changes in psychological distress, depression, and anxiety across treatment. We explored this in two ways, given that some measures were also administered prior to each lesson, while others were administered only at pre, post, and follow-up timepoints.
a)
Lesson-by-lesson mediation. First, we examined whether changes in RNT after each treatment session mediated lower levels of distress at the next lesson. No studies to our knowledge have examined session-by-session mechanisms of change in RNT-focused interventions. However, Patel et al. (2023) measured rumination and depression symptom severity periodically throughout CBT treatment for depression in an outpatient tertiary setting. They found that lower rumination levels at each treatment time point prospectively predicted lower symptoms of depression at the next time point. Based on these findings, and the findings of Watkins et al. (2011) and Topper et al. (2017) that reductions in depression symptoms (or likelihood of developing depression or anxiety symptoms) were mediated by changes in RNT during treatment, we hypothesised that changes in RNT at each time point would predict changes in distress at the following timepoint.
 
b)
Pre- to post and follow-up mediation. Next, we examined whether changes in RNT mediated the effect of treatment from pre- to post-treatment and follow-up on the key clinical outcome measures (depression, anxiety, and distress symptoms). As more measures were available, we examined this using both the transdiagnostic measure of RNT (RTQ-10) and specific measures of maladaptive rumination (the Ruminative Response Scale—Brooding Subscale; RRS—Brooding; Treynor et al., 2003) and worry (the Penn State Worry Questionnaire; PSWQ; Meyer et al., 1990), to determine whether the same pattern of mediation was observed in both sub-types of RNT. Based on evidence that reductions in RNT are associated with decreases in depressive and anxiety symptoms in CBT interventions (Newby et al., 2014; Spinhoven et al., 2018), as well as the mediation findings in the studies of RNT-focused treatments by Watkins et al (2011) and Topper et al (2017) above, we hypothesised that reductions in RNT would mediate the reductions in pre-to post-treatment and follow-up severity of depression, anxiety, and distress.
 
 
3)
Predictors of treatment response. Our final aim was to explore predictors of treatment response, in order to identify which individuals benefit most from this treatment. Owing to the lack of previous research in RNT-focused interventions, we based our hypotheses on studies of general CBT interventions for depression and anxiety, which show that participants with higher baseline depression and anxiety severity, and higher baseline rumination and worry, show better treatment response (Barrio-Martínez et al., 2023; Karyotaki et al., 2021; Niles et al., 2021; Reins et al., 2021). We have also referred to the literature on treatment expectancy as a predictor of better treatment outcome (Tambling, 2012), despite Wallsten et al.’s (2023) finding that treatment expectancy was not correlated with change in group RF-CBT. Therefore, we hypothesised that higher baseline severity (RNT and depression and anxiety symptom severity), and higher treatment expectations, would predict better response to treatment.
 

Method

Setting, Participants and Procedure

This study used secondary data from the RCT (Joubert et al., 2023) that compared the online Managing Rumination and Worry program delivered with or without clinician guidance to a treatment-as-usual (TAU) control condition in which participants accessed the program in self-help format after an 18-week waiting period. For a full description of the study’s methods, including other measures assessed not presented in this paper, see (Joubert et al., 2023). The RCT was approved by St Vincent’s Hospital Sydney Human Research Ethics Committee (HREC/18/SVH/220) and prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN 12620000959976).
In brief, eligible participants were aged 18 years or older, lived in Australia, were fluent in English, had access to a computer and internet, and experienced elevated levels of rumination and/or worry (RTQ-10 total score ≥ 28). Participants were excluded if their RTQ-10 score was ≤ 27, they had severe depression (Patient Health Questionnaire-9 [PHQ-9; Kroenke et al., 2001a] total score > 23), were actively suicidal, self-reported diagnoses of schizophrenia, bipolar disorder, or psychosis, commenced psychological therapy in the preceding month, commenced or changed dosage of depression or anxiety medication in the preceding two months, or enrolled in an online program for depression or anxiety in the preceding year.
Participants were recruited between August 2020 and March 2021, via social media advertisements and email newsletters. Eligible participants completed informed consent, eligibility screening and demographic questionnaires online, before completing a brief telephone interview including a structured diagnostic interview (abbreviated Anxiety and Related Disorders Interview Schedule for DSM-5; ADIS-5; Brown & Barlow, 2014) to assess current and past MDD and GAD diagnoses, and a risk assessment. They were then randomly assigned to either the 3-lesson clinician-guided or self-guided online intervention program, or the TAU waitlist control group. All participants were able to continue with any current psychological or pharmacological treatment (except those specified in the exclusion criteria) but were discouraged from commencing new treatments during the study participation period.
Participants completed online self-report measures at pre-treatment (immediately prior to Lesson 1), post-treatment (one week after completing Lesson 3), and at three-month follow-up (12 weeks after post-treatment). They also completed a measure of RNT (the RTQ-10) and distress (the K-10) prior to each lesson. The ADIS-5 MDD and GAD modules were re-administered by a Clinical Psychologist during the 3-month follow-up telephone interview.

Measures

Repetitive Thinking Questionnaire-10 (RTQ-10; McEvoy et al., 2010). The RTQ-10 is a transdiagnostic measure of the extent to which an individual engages in RNT in response to distressing situations. The scale has demonstrated excellent internal consistency across both clinical and non-clinical samples (α’s = 0.89–0.94; McEvoy et al., 2014, 2018), and high convergent and divergent validity (Mahoney et al., 2012; McEvoy et al., 2010, 2014).
Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001b). The PHQ-9 is a reliable and widely validated measure of depression symptom severity over the past two weeks (Kroenke et al., 2001b, 2016; Titov et al., 2011). It has good internal consistency (α = 0.86–0.89), test–retest reliability (r = 0.84), sensitivity and specificity (both 0.88), construct validity, and convergent validity (Kroenke et al., 2001b, 2016).
Generalised Anxiety Disorder 7-item Scale (GAD-7; Spitzer et al., 2006). The GAD-7 is a brief self-report scale that measures general anxiety symptom severity over the past two weeks. It has strong reliability and validity in identifying probable DSM-IV GAD (American Psychiatric Association, 2013), hand symptom severity, in both psychiatric and general populations (α = 0.89–0.92; Löwe et al., 2008; Plummer et al., 2016; Spitzer et al., 2006).
Kessler Psychological Distress Scale—10-item (K-10; Kessler et al., 2002). The K-10 is a 10-item screening measure of psychological distress over the past two weeks. It has strong psychometric properties across a wide range of samples including good discriminant validity between clinical and non-clinical samples (Kessler et al., 2002), convergent validity (Andrews & Slade, 2001), temporal stability (ICC = 0.86–0.89, r = 0.76–0.80; Merson et al., 2021), and high internal consistency (α = 0.93; Kessler et al., 2002).
Ruminative Response Scale– Brooding Subscale (RRS-Brooding; Treynor et al., 2003). This 5-item scale is a subset of the original 10-item measure of rumination, the RRS, and measures the more maladaptive form of rumination, brooding. The scale possesses strong predictive validity for depression (Schoofs et al., 2010), test re-test reliability and internal consistency (α = 0.69–0.78; Schoofs et al., 2010), convergent validity with other measures of rumination and depression (Griffith & Raes, 2014; Schoofs et al., 2010; Valencia & Paredes-Angeles, 2022), and discriminant validity (Schoofs et al., 2010).
Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990). This 16-item questionnaire measures trait worry, including intensity, frequency, and perceived uncontrollability. It possesses good psychometric properties (Zlomke, 2009), with high internal consistency (α = 0.86–0.95; Brown et al., 1992), and test–retest reliability (r = 0.74—0.93; Meyer et al., 1990), good convergent validity with other measures of worry, anxiety and depression (Brown et al., 1992; Van Rijsoort et al., 1999), and good discriminant validity (Brown et al., 1992).
Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000). This is a brief measure of participants’ perception of the credibility and perceived benefit of a treatment which was administered prior to completion of Lesson 1 of the program. It has high internal consistency (α = 0.85–0.090) and test–retest reliability, and good predictive validity for treatment outcome (Devilly & Borkovec, 2000).

Description of Intervention

The Managing Rumination and Worry Program comprises three lessons, delivered via an online research platform (e.g., The Virtual Clinic), that participants complete over a period of three to six weeks. Lessons are in the form of an illustrated comic-style story following two fictional characters who learn to better manage rumination and worry. Slides follow the character’s stories, introduce treatment skills, and show their application in the characters’ lives.
Program content1 (see Table 1) was informed by several CBT approaches. Drawing on RF-CBT, for example, participants learn to recognise when they are ruminating or worrying, identify their individual warning signs, proactively plan activities for high-risk times, and practice more adaptive alternative strategies such as structured problem-solving (Watkins, 2018). Using skills from MBCT (Segal et al., 2018), participants learn to shift their attention away from ruminating or worrying to focus on the present moment. Another lesson teaches participants to recognise when they are engaging in an unhelpful, abstract and evaluative thinking style characteristic of rumination, and encourages them to shift to a more helpful thinking style that is specific and action-oriented, or ‘concrete’ (Watkins et al., 2007, 2012).
Table 1
Brief summary of the Managing Rumination and Worry Program content
Lesson
Skills overview
1
Psychoeducation about rumination and worry
Self-monitoring of rumination/worry
Activity Planning for “high risk” times
2
Three Rules of Thumb to differentiate helpful vs unhelpful rumination/worry
Structured Problem Solving
Worry Time
Disengaging from rumination/worry by Shifting Attention onto present moment
3
Managing Rumination and Worry at Night
Shifting from General to Specific Thinking
Summary of program content and relapse prevention
After each lesson participants download a one-to-two page lesson summary of key concepts and skills and an action plan for practicing the skills over the coming week. Optional extra resources are also accessible. A lesson is considered complete once all lesson slides have been viewed and the lesson summary/activity plan downloaded. The program is self-paced; one sequential lesson is made available each week, and a five-day lockout period between lessons encourages participants to revise and practice the previous lesson skills before accessing the next module. Participants received automated email and SMS reminders from the Virtual Clinic platform to complete lessons, questionnaires, and practice activities to encourage adherence and engagement. Participants in the clinician-guided group received brief, semi-structured check-in calls from a Provisional or Clinical Psychologist in the days following lesson completion to help summarise treatment content, answer questions, provide encouragement, and assist with implementation of treatment skills. All participants had access to technical support throughout the treatment period. Clinical and research staff also contacted participants by phone or email if they had failed to log in or complete the next lesson, or to assess their safety in response to a significant deterioration in their PHQ-9 or K-10 scores.

Statistical Analyses

1.
Pattern of symptom change across treatment: Intention to treat linear mixed models, with fixed effects of group (clinician-guided versus self-guided), time, and group by time interaction effect were conducted to explore lesson-by-lesson changes in a) RTQ-10 and b) K-10 scores. All models included a random intercept for each subject. Pairwise comparisons, with Bonferroni corrections applied for multiple comparisons, examined whether there were statistically significant changes in scores between each lesson. In the original RCT study, significant baseline group differences were found for depression (PHQ-9) and anxiety (GAD-7) symptom severity, and current psychotherapy (see (Joubert et al., 2023) for further detail). Accordingly, we repeated the analyses controlling for these baseline variables as covariates. These and the predictor analyses were performed in IBM SPSS Statistics v28.0.1.0.
 
2.
Mediation analyses. Longitudinal mediation analysis of RNT changes on outcome variables was initially planned and conducted using a random-intercept cross-lagged panel model (RI-CLPM). However, the goodness of fit measure of the RI-CLPM model did not achieve the optimal convergence. Therefore, we conducted alternate Structural Equation Modelling (SEM)-based mediation analyses. The total effect was decomposed into direct and indirect effects with the indirect effect accounting for the magnitude of the mediation. An alpha of 0.05 was used to determine statistical significance. Mediation analyses were performed in R, version 4.3.4, and STATA version 18.0.
a)
Lesson-by-lesson mediation. The mediating effect of changes in RNT (RTQ-10) on changes in distress (K-10) was analysed across three intervals: from Lesson 1 to Lesson 2, from Lesson 2 to Lesson 3, and from Lesson 3 to post-intervention. To test whether the reverse pattern of mediation occurred, the mediating effect of changes in distress (K-10) on RNT (RTQ-10) was repeated across the three intervals above (Lesson 1 to 2, 2 to 3, and 3 to post-treatment).
 
b)
Pre-post and follow-up mediation. Mediation analyses were repeated to separately assess the mediation effect of RNT (measured by changes in the RTQ-10), then worry (PSWQ), and rumination (RRS-Brooding), on longitudinal changes in depression (PHQ-9), anxiety (GAD-7), and distress (K-10). These analyses were conducted separately for the pre- to post-treatment outcomes, and post-treatment to 3-month follow-up outcomes.
 
 
3.
Predictor analyses. To investigate whether the hypothesised predictor variables (treatment expectancy, and baseline depression, anxiety, RNT, worry, and rumination) predicted treatment outcomes (over and above initial symptoms and treatment group), we conducted separate linear mixed models with each outcome measure as the dependent variable (DV). In these models, we included fixed effects of time and treatment group allocation (clinician-guided or self-help), as well as each of the hypothesised predictor variables (e.g., treatment expectancy, baseline depression symptoms, baseline anxiety, baseline repetitive thinking variables). Treatment condition was included as a variable given the results of the original RCT; i.e., that participants in the clinician-guided condition had better outcomes. All models included a random intercept for each subject to account for individual differences in treatment response.
 

Results

Pattern of Symptom Change Across Treatment

Estimated marginal means and between-group comparisons for RTQ-10 and K-10 scores across treatment (lesson-by-lesson) and follow-up are presented in Table 2, with results of the covariate-adjusted analyses (controlling for baseline PHQ-9 and GAD-7, and current psychotherapy) presented in Table 3.
Table 2
Estimated marginal means for repetitive negative thinking (RTQ-10) and distress (K-10) by lesson and treatment group
Measure
Group
Baseline (Pre-Lesson 1)
Lesson 2
Lesson 3
Post-treatment
3-Month follow-up
L1-L2
L2-L3
L3-Post
Post-FU
EMM
SD
EMM
SD
EMM
SD
EMM
SD
EMM
SD
Hedges g (95% CI)
Hedges g (95% CI)
Hedges g (95% CI)
Hedges g (95% CI)
RTQ-10
Clinician guided
38.67
7.30
36.57
7.65
33.04
8.11
28.39
8.03
25.48
8.47
0.28 (-0.16, 0.72)
0.44 (-0.04, 0.92)
0.57 (0.08, 1.05)*
0.35 (-0.16, 0.86)
 
Self-help
41.06
7.30
38.63
7.49
35.03
7.80
31.71
7.95
32.58
8.18
0.33 (-0.09, 0.75)
0.47 (0.02, 0.92)*
0.42 (-0.04, 0.88)
0.11 (-0.37, 0.58)
K-10
Clinician guided
23.93
7.45
22.71
7.63
20.35
7.85
18.25
7.81
17.15
8.02
0.16 (-0.28, 0.60)
0.30 (-0.18, 0.78)
0.27 (-0.21, 0.74)
0.14 (-0.37, 0.64)
 
Self-help
27.30
7.45
25.25
7.55
24.76
7.69
23.12
7.76
22.12
7.90
0.27 (-0.15, 0.69)
0.06 (-0.38, 0.51)
0.21 (-0.25, 0.67)
0.13 (-0.36, 0.61)
EMM: Estimated marginal means, SD: Standard deviation, RTQ-10: Repetitive Thinking Questionnaire – 10, K-10: Kessler Psychological Distress Scale – 10 item, CI: Confidence Interval
*significant at .05 level (p <.05)
Table 3
Estimated Marginal means for repetitive negative thinking (RTQ-10) and distress (K-10) by lesson and treatment group (covariate-adjusted analyses)
Measure
Group
Baseline (Pre-Lesson 1)
Lesson 2
Lesson 3
Post-treatment
3-Month Follow-Up
L1-L2
L2-L3
L3-Post
Post-FU
EMM
SD
EMM
SD
EMM
SD
EMM
SD
EMM
SD
Hedges g (95% CI)
Hedges g (95% CI)
Hedges g (95% CI)
Hedges g (95% CI)
RTQ-10
Clinician guided
38.88
7.49
36.77
7.78
33.20
8.26
28.56
8.19
25.65
8.63
0.27 (-0.17, 0.71)
0.44 (-0.04, 0.92)
0.56 (0.07, 1.04)*
0.34 (-0.17, 0.85)
Self-help
40.61
6.90
38.18
7.10
34.56
7.42
31.27
7.56
32.14
7.79
0.34 (-0.08, 0.77)
0.49 (0.04, 0.94)*
0.43 (-0.03, 0.90)
0.11 (-0.36, 0.59)
K-10
Clinician guided
25.12
5.31
23.90
5.49
21.41
5.80
19.35
5.75
18.13
6.02
0.22 (-0.22, 0.66)
0.44 (-0.04, 0.92)
0.35 (-0.13, 0.83)
0.20 (-0.30, 0.71)
Self-help
26.33
4.85
24.28
4.98
23.77
5.18
22.11
5.27
21.03
5.47
0.41 (-0.01, 0.84)
0.10 (-0.34, 0.54)
0.31 (-0.14, 0.77)
0.20 (-0.28, 0.68)
EMM: Estimated marginal means, SD:  Standard deviation, RTQ-10: Repetitive Thinking Questionnaire – 10, K-10:  Kessler Psychological Distress Scale – 10 item
significant at .05 level (p <.05), CI = Confidence Interval
a) Changes in RNT across treatment. There was a significant effect of time (F(4, 294) = 56.99, p < 0.001), group (F(1, 89) = 7.85, p = 0.006), and a time by group interaction (F(4, 293) = 2.67, p = 0.032), showing that RNT reduced in both online treatment groups, with a larger reduction on the RTQ-10 observed in the clinician-guided group. As can be seen in Table 2 and Fig. 1, RTQ-10 scores improved across treatment and to follow-up, in both treatment groups. Both treatment groups experienced small to medium reductions in RNT after each lesson (within-group effect sizes ranging from 0.28 to 0.57; see Table 2 for effect sizes and confidence intervals). In the clinician-guided group, there was a significant reduction in RTQ-10 scores between Lesson 3 and post-treatment (p = 0.003), and the reduction in RTQ-10 between Lesson 2 and 3 approached significance (p = 0.052). In the self-help group, the only statistically significant reduction was between Lesson 2 and 3 (p = 0.024).
The same pattern of results was found in the covariate-adjusted analyses (see Table 3) with the only exception being that in the clinician-guided group, the reduction in RNT between Lesson 2 and 3 was statistically significant (p = 0.046).
b) Changes in Distress across treatment. There was a significant effect of time (F(4, 287) = 34.29, p < 0.001) and group (F(1, 90) = 7.91, p = 0.006), but no time by group interaction (F(4, 287) = 1.65, p = 0.162), showing that distress (K-10 scores) reduced in both treatment groups (see Fig. 2, and Table 2 for results including within-group effect sizes and confidence intervals). Examining lesson-by-lesson scores on the K-10, both groups experienced small but mostly non-significant improvements in distress after each lesson, with within-group effect sizes ranging from 0.06 to 0.30. In the clinician-guided group, the only statistically significant reduction in distress occurred between Lesson 2 and 3 (p = 0.046). In the self-help group the largest reduction in distress occurred between Lesson 1 and 2, approaching statistical significance (mean difference = 2.05, p = 0.060; see Table 2). The same pattern of findings was observed in the covariate-adjusted analyses (see Table 3).

Mediating Effect of RNT

Lesson-By-Lesson Mediation

Mediating Effect of RNT on Distress
The mediating effect of changes in RNT (RTQ-10) on changes in distress (K-10) was analysed across three intervals: from Lesson 1–2, from Lesson 2–3, and from Lesson 3 to post-intervention; see Table 4. From Lesson 1 to Lesson 2, the overall indirect effect was β = 0.036 (95% CI − 0.02–0.10), indicating a non-significant reduction in distress mediated by changes in repetitive negative thinking (with 58.2% of this effect attributed to the indirect pathway). Although the magnitude of the effect was larger in the self-help group than the clinician-guided group (62.7% vs. 6.5% of the total effect), both mediation effects remained non-significant (clinician-guided: β = 0.014, 95% CI − 0.08–0.11; self-help: β = 0.05, 95% CI − 0.01–0.12).
Table 4
Lesson-wise mediation of distress levels (K-10) by changes in RNT (RTQ-10)
Time
Group
Indirect effect
Proportion of total effect mediated
β (95% CI)
Lessons 1-2
Overall
0.036 (-0.02– 0.10)
0.582
Clinician-guided
0.014 (-0.08– 0.11)
0.065
Self-help
0.05 (-0.01– 0.12)
0.627
Lessons 2-3
Overall
0.08 (0.02—0.14) *
1.85
Clinician-guided
0.13 (0.03—0.25) *
2.41
Self-help
0.05 (-0.04– 0.15)
0.91
Lesson 3-Post
Overall
0.02 (-0.06– 0.10)
0.07
Clinician-guided
0.03 (-0.03– 0.13)
0.09
Self-help
0.01 (-0.14– 0.14)
0.03
CI: confidence interval
*significant at .05 level (p <.05)
From Lesson 2 to Lesson 3, the results showed a significant overall indirect effect of β = 0.08 (95% CI 0.02–0.14), indicating a significant reduction in distress levels through changes in repetitive negative thinking with the magnitude of the mediated effect 1.85 times that of the total effect. In the clinician-guided subgroup, the indirect effect was notably stronger (2.41 times that of the total effect) at β = 0.13 (95% CI 0.03–0.25), demonstrating a significant mediating effect of RNT on distress. However, in the self-help subgroup, the indirect effect was non-significant, β = 0.05 (95% CI − 0.04–0.15).
From Lesson 3 to the post-intervention period, there was no evidence of the mediation effect of change in RNT on distress for overall, clinician-guided, and self-help subgroups with a relatively small proportion of total effect mediated by RNT changes (7% for overall, 9% for clinician-led and 3% for self-help subgroup).
Mediating effect of distress on RNT
The mediating effect of changes in distress (K-10) on RNT (RTQ-10) was repeated across the three intervals above (Lesson 1–2, 2–3, and 3 to post-treatment). As above, the mediating effect of change in distress on change in RNT showed variability across different lessons and groups, but no effects reached statistical significance (see Table 5). Only one indirect mediating effect of changes in distress on changes in RNT bordered on statistical significance: from Lesson 3 to post-intervention, in the clinician-guided group there was an indirect effect of β =  − 0.08 (95% CI − 0.21–0.003), with a substantial 56.9% mediation. No other effects were statistically significant.
Table 5
Lesson-wise mediation of RNT levels (RTQ-10) by changes in distress (K-10)
Time
Group
Indirect effect
Proportion of total effect mediated
β (95% CI)
Lessons 1—2
Overall
0.04 (− 0.03– 0.13)
0.137
Clinician-guided
0.07 (− 0.05– 0.23)
0.192
Self-help
0.02 (− 0.08– 0.11)
0.057
Lessons 2—3
Overall
0.02 (− 0.12– 0.16)
0.066
Clinician-guided
 − 0.03 (− 0.19– 0.09)
0.278
Self-help
0.13 (-0.08– 0.39)
0.291
Lesson 3—Post
Overall
 − 0.02 (− 0.13– 0.09)
0.084
Clinician-guided
 − 0.08 (− 0.21– 0.003)
0.569
Self-help
0.03 (− 0.21– 0.27)
0.104
CI: confidence interval

Pre- to Post and Follow-Up Mediation

Mediating Effect of RNT
For the overall sample, the pre- to post-treatment change in RNT (RTQ-10) on post-treatment depression (PHQ-9), anxiety (GAD-7), and distress (K-10) showed small indirect mediating effects, none of which reached statistical significance (see Table 6), with the proportion of total effect mediated ranging from 0.03 to 0.14 (3–14%). When each sub-group (clinician-guided and self-help) was analysed separately, the indirect mediation effects of RNT for each outcome variable were similarly small and non-significant.
Table 6
Mediation effect of changes in RNT (RTQ-10) on longitudinal changes in depression (PHQ-9), anxiety (GAD-7), and distress (K-10)
Time
Group
Depression (PHQ-9)
Anxiety (GAD-7)
Distress (K-10)
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
β (95% CI)
Proportion
β (95% CI)
Proportion
β (95% CI)
Proportion
Pre-Post
Overall
0.03 (− 0.03– 0.09)
0.04
0.08 (− 0.02– 0.19)
0.14
0.02 (− 0.06– 0.09)
0.03
Clinician-guided
0.002 (− 0.08– 0.08)
0.01
0.03 (− 0.08– 0.15)
0.09
0.01 (− 0.12– 0.14)
0.01
Self-help
0.01 (− 0.07– 0.11)
0.02
0.02 (− 0.22– 0.25)
0.04
0.004 (− 0.12– 0.13)
0.01
Post-FU
Overall
0.06 (0.01– 0.13)*
0.07
0.04 (− 0.03– 0.12)
0.05
0.06 (0.00– 0.13)
0.07
Clinician
0.02 (− 0.05– 0.13)
0.04
0.01 (− 0.07– 0.09)
0.02
0.04 (− 0.09– 0.24)
0.07
Self-help
0.02 (− 0.02– 0.07)
0.02
0.09 (− 0.06– 0.35)
0.12
0.04 (− 0.04– 0.18)
0.06
FU:  3-month follow-up, CI: confidence interval
* significant at .05 level (p <.05)
In the post-intervention to 3-month follow-up period, there was a significant indirect effect of RNT on depression overall collapsed across treatment groups (β = 0.06, 95% CI 0.01–0.13), with 7% of the total effect being mediated. However, when assessing clinician-led or self-help subgroups separately, there was no evidence of the significant mediation effect. There were also no significant mediation effects of post- to follow-up changes in RNT on post to follow-up changes in anxiety or distress, either overall or for the subgroups separately.
Mediating Effect of Worry
The mediating effect of changes in worry on changes in depression, anxiety, and distress also varied across periods and groups, with none of the effects reaching statistical significance (see Table 7). There were no significant mediation effects of changes in worry from pre-to post-treatment on pre- to post-treatment changes in depression, anxiety, or distress, either overall or for the subgroups separately. There were also no significant mediation effects of worry on the outcomes from post-treatment to follow-up.
Table 7
Mediation effect of changes in worry (PSWQ) on longitudinal changes in depression (PHQ-9), anxiety (GAD-7), and distress (K-10)
Time
Group
Depression (PHQ9)
Anxiety (GAD7)
Distress (K10)
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
β (95% CI)
Proportion
β (95% CI)
Proportion
β (95% CI)
Proportion
Pre-Post
Overall
0.004 (− 0.04– 0.05)
0.01
0.10 (− 0.004– 0.22)
0.141
0.03 (− 0.02– 0.10)
0.04
Clinician-guided
0.01 (− 0.03– 0.06)
.026
0.07 (− 0.004– 0.17)
0.169
0.04 (− 0.03– 0.12)
0.07
Self-help
0.03 (− 0.04– 0.12)
.037
0.02 (− 0.13– 0.19)
0.04
0.05 (− 0.07– 0.17)
0.054
Post-FU
Overall
0.04 (− 0.001– 0.09)
0.04
0.07 (− 0.001– 0.16)
0.087
0.04 (− 0.01– 0.11)
0.057
Clinician-guided
0.01 (− 0.06– 0.09)
0.01
0.01 (− 0.08– 0.11)
0.033
0.02 (− 0.07– 0.16)
0.039
Self-help
0.01 (− 0.03– 0.06)
0.01
0.01 (− 0.12– 0.15)
0.008
0.01 (− 0.06– 0.09)
0.009
FU: 3-month follow-up, CI: confidence interval
*significant at .05 level (p <.05); **significant at .01 level (p <.01)
Mediating Effect of Rumination
The mediating effect of changes in rumination (RRS-Brooding) on changes in depression, anxiety, and distress also varied across periods and groups (see Table 8). From pre- to post-intervention, no mediating effects of rumination were statistically significant either overall or for each subgroup.
Table 8
Mediation effect of changes in rumination (RRS-Brooding) on longitudinal changes in depression (PHQ-9), anxiety (GAD-7), and distress (K-10)
Time
Group
Depression (PHQ9)
Anxiety (GAD7)
Distress (K10)
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
Indirect effect
Total effect mediated
β (95% CI)
Proportion
β (95% CI)
Proportion
β (95% CI)
Proportion
Pre-Post
Overall
0.01 (− 0.04– 0.06)
0.015
− 0.001 (− 0.08– 0.08)
0.001
0.01 (− 0.03– 0.06)
0.012
Clinician-guided
0.04 (− 0.002– 0.10)
0.084
0.02 (− 0.06– 0.10)
0.043
0.04 (− 0.01– 0.11)
0.08
Self-help
− 0.04 (− 0.17– 0.06)
0.056
− 0.11 (− 0.30– 0.02)
0.228
− 0.13 (− 0.29—0.01)
0.157
Post-FU
Overall
0.07 (− 0.002– 0.13)
0.072
0.02 (− 0.02– 0.08)
0.025
0.07 (0.01– 0.14)*
0.079
Clinician-guided
0.001 (− 0.04– 0.04)
0.002
− 0.01 (− 0.07– 0.04)
0.039
− 0.001 (− 0.04– 0.04)
0.001
Self-help
0.15 (0.05– 0.29)*
0.155
0.15 (− 0.004– 0.35)
0.174
0.24 (0.11– 0.40)**
0.313
FU = 3-month follow-up; CI confidence interval; *significant at .05 level (p <.05); **significant at .01 level (p <.01)
From post-intervention to 3-month follow-up, however, there was a significant overall indirect effect of rumination on follow-up distress (K-10 scores, β = 0.07, 95% CI 0.01–0.14, mediating 7.9%). The effects on depression and anxiety were not significant (depression: β = 0.07, 95% CI − 0.002–0.13; anxiety: β = 0.02, 95% CI − 0.02–0.08).
In the clinician-led group, there were no significant mediation effects of rumination on follow-up outcome variables. In the self-help group, there was a significant mediation effect of rumination on follow-up depression (β = 0.15, 95% CI 0.05–0.29) and distress (β = 0.24 (95% CI 0.11–0.40), but not anxiety (β = 0.15 (95% CI − 0.004–0.35), mediating 15.5%, 17.4%, and 31.3%, respectively.

Predictors of Treatment Response

Coefficients and statistics for the predictor analyses are presented in Table 9 (Depression and anxiety outcome measures: PHQ-9 and GAD-7) and Table 10 (Repetitive Negative Thinking outcome variables: RTQ-10, PSWQ and RRS-Brooding). For each outcome measure (PHQ-9, GAD-7, RTQ-10, PSWQ and RRS-Brooding), higher severity at baseline predicted higher severity of that same measure. Treatment condition was also a significant predictor of anxiety (GAD-7) in favour of the clinician-guided group (i.e., assignment to the clinician-guided treatment group predicted lower scores following treatment). Over and above baseline severity and treatment group, the principle significant predictors of treatment outcomes were baseline treatment expectancy (CEQ), and baseline rumination (RRS). Higher treatment expectancy at baseline significantly predicted lower scores on all measures. In addition, higher baseline rumination on the RRS significantly predicted higher depression (PHQ-9), and approached significance as a predictor of higher anxiety scores (GAD-7; p = 0.052).
Table 9
Predictors of outcome on the PHQ-9 and GAD-7
 
Estimate
SE
df
T
p
95% Confidence Interval
Lower
Upper
DV = PHQ-9
Intercept
0.74
2.07
90.54
0.36
0.72
− 3.37
4.85
Pre
3.82
0.41
163.15
9.39
 < 0.001**
3.02
4.63
Post
0.42
0.43
155.21
1.00
0.32
− 0.42
1.27
Follow-up
0.00
0.00
     
Clinician-guided
− 0.59
0.39
86.48
− 1.49
0.14
− 1.37
0.19
Self-guided
0.00
0.00
     
CEQ
− 0.15
0.04
88.94
− 3.47
 < 0.001**
− 0.24
− 0.06
RTQ
0.02
0.04
87.90
0.50
0.62
− 0.06
0.10
PHQ-9
0.70
0.05
80.98
15.61
 < 0.001**
0.61
0.79
GAD-7
− 0.03
0.05
92.76
− 0.55
0.58
− 0.14
0.08
PSWQ
0.00
0.03
99.86
0.18
0.86
− 0.05
0.06
RRS-Brooding
0.17
0.07
81.85
2.41
0.02*
0.03
0.31
DV = GAD-7
Intercept
1.62
2.18
216.00
0.74
0.46
− 2.69
5.92
Pre
4.68
0.48
216.00
9.76
 < 0.001**
3.74
5.63
Post
0.39
0.50
216.00
0.78
0.43
− 0.60
1.39
Follow-up
0.00
0.00
     
Clinician-guided
− 1.31
0.41
216.00
− 3.16
 < 0.001**
− 2.13
− 0.49
Self-guided
0.00
0.00
     
CEQ
− 0.10
0.05
216.00
− 2.14
0.03*
− 0.19
− 0.01
RTQ
0.02
0.04
216.00
0.57
0.57
− 0.06
0.11
PHQ-9
0.02
0.05
216.00
0.42
0.67
− 0.07
0.11
GAD-7
0.64
0.06
216.00
11.23
 < 0.001**
0.52
0.75
PSWQ
− 0.03
0.03
216.00
− 1.02
0.31
− 0.09
0.03
RRS-Brooding
0.14
0.07
216.00
1.95
0.05
0.00
0.29
*significant at .05 level (p <.05); **significant at .01 level (p <.01)
Table 10
Predictors of outcome on the RTQ-10, PSWQ and RRS
 
Estimate
SE
df
T
P
95% Confidence Interval
Lower
Upper
DV = RTQ-10
Intercept
9.89
5.26
94.55
1.88
0.06
− 0.55
20.33
Pre
10.45
0.94
165.21
11.06
 < 0.001**
8.58
12.31
Post
0.87
0.99
157.28
0.88
0.38
− 1.08
2.82
Follow-up
0.00
0.00
     
Clinician-guided
− 1.41
1.01
92.94
− 1.39
0.17
− 3.41
0.60
Self-guided
0.00
0.00
     
CEQ
− 0.27
0.11
93.58
− 2.43
0.02*
− 0.49
− 0.05
RTQ
0.59
0.10
93.97
5.78
 < 0.001**
0.38
0.79
PHQ-9
0.10
0.12
87.62
0.85
0.40
− 0.13
0.33
GAD-7
− 0.05
0.14
99.03
− 0.36
0.72
− 0.32
0.22
PSWQ
0.00
0.07
104.89
− 0.02
0.99
− 0.14
0.14
RRS-Brooding
0.31
0.18
88.29
1.72
0.09
− 0.05
0.66
DV = PSWQ
Intercept
15.35
6.04
94.44
2.54
0.01*
3.36
27.34
Pre
10.70
1.10
163.95
9.72
 < 0.01**
8.53
12.88
Post
2.24
1.15
155.06
1.95
0.05
− 0.02
4.51
Follow-up
0.00
0.00
     
Clinician-guided
− 1.57
1.15
91.08
− 1.36
0.18
− 3.86
0.72
Self-guided
0.00
0.00
     
CEQ
− 0.31
0.13
93.43
− 2.44
0.02*
− 0.56
− 0.06
RTQ
− 0.04
0.12
92.16
− 0.36
0.72
− 0.27
0.19
PHQ-9
− 0.05
0.13
86.30
− 0.36
0.72
− 0.31
0.22
GAD-7
0.10
0.16
97.16
0.66
0.51
− 0.21
0.41
PSWQ
0.70
0.08
103.33
8.80
 < 0.001**
0.54
0.86
RRS-Brooding
0.27
0.20
86.55
1.35
0.18
− 0.13
0.68
DV = RRS-Brooding
Intercept
0.79
1.54
94.03
0.51
0.61
− 2.27
3.85
Pre
2.64
0.30
165.32
8.88
 < 0.001**
2.05
3.22
Post
0.78
0.31
156.36
2.53
0.01*
0.17
1.40
Follow-up
0.00
0.00
     
Clinician-guided
− 0.47
0.29
90.22
− 1.59
0.12
− 1.05
0.12
Self-guided
0.00
0.00
     
CEQ
− 0.08
0.03
92.63
− 2.58
0.01*
− 0.15
− 0.02
RTQ
0.00
0.03
91.54
− 0.11
0.91
− 0.06
0.06
PHQ-9
0.05
0.03
85.16
1.40
0.17
− 0.02
0.11
GAD-7
− 0.02
0.04
96.47
− 0.57
0.57
− 0.10
0.06
PSWQ
0.00
0.02
103.25
0.23
0.82
− 0.04
0.05
RRS-Brooding
0.80
0.05
85.54
15.51
 < 0.001**
0.70
0.91
* significant at .05 level (p <.05); ** significant at .01 level (p <.01)

Discussion

This study is one of the first to investigate mediators and predictors of treatment outcome in a brief, online RNT-focused intervention for adults, the Managing Rumination and Worry Program. We found that RNT and distress gradually reduced over the course of treatment in both self-guided and clinician-guided treatment groups, with the largest improvements occurring after Lessons 2 and 3. While we predicted that changes in RNT would mediate lesson-by-lesson and pre- to post-treatment changes in outcome measures, the pattern of mediation findings was mixed, with no clear mediation pattern emerging. Our results also showed that baseline severity of depression, anxiety, distress, and RNT (particularly rumination)—and over and above these, treatment expectancy—were significant predictors of treatment outcome.

Pattern of Symptom Change Across Treatment

Studies that examine the pattern of improvement across treatment, and identify which treatment modules produce the greatest change, are important to further optimise effective treatments and increase our understanding of how they work (Watkins & Newbold, 2020). In this study, we found that both treatment groups improved throughout the program and to follow-up, with small to moderate improvements in RNT and distress after each lesson, consistent with other studies of efficacious treatments showing a gradual course of symptom improvement (e.g., Andrews et al., 2020; Skelton et al., 2023). The smallest improvements in RNT occurred after Lesson 1 (within-group Hedge’s g: 0.28–0.33), which focused on psychoeducation and monitoring, and between post-treatment and follow-up (within group g’s = 0.11–0.34), whereas the largest improvements occurred following the lessons containing the core therapeutic skills, from Lesson 2 to 3 (within-group g’s = 0.44–0.49), and from Lesson 3 to post-treatment (within-group g’s = 0.43–0.56). Distress decreased gradually in small to moderate increments after each lesson and to follow-up. The larger reductions in RNT after Lessons 2 and 3 suggest that the active treatment strategies in these sessions (i.e., structured problem-solving, worry time, disengaging from RNT, concreteness training) are more powerful in reducing RNT than less specific treatment elements of psychoeducation and monitoring in Lesson 1. It appears that these treatment components are effective at reducing RNT and distress, despite the brevity of the treatment, thus are important elements to retain in future iterations of the program. It is still unclear however which of these strategies are driving the benefit. In a recent dismantling study, Watkins et al. (Watkins et al., 2023) examined which CBT treatment components (including RNT-focused strategies such as concreteness training) were most effective in reducing depression. Although absorption training was found to be important, it was still unclear which treatment strategies were most potent in driving change. Absorption training teaches skills to help patients to become immersed in positive activities (Watkins et al., 2012, 2023), and shares similarities with the attention shifting/disengaging from RNT skills in Lesson 2 of this program as well as activity scheduling in Lesson 1. Further dismantling studies of RNT-focused treatments such as the Managing Rumination and Worry Program are important to identify the most active ingredients of these treatments; for example, using experimental designs that test the effects of single ingredients.

Mediating Effects of RNT

As the current treatment was designed to reduce symptoms of depression, anxiety and distress through reducing RNT, we hypothesised that changes in RNT lesson-by-lesson, and across treatment to the follow-up period, would mediate the reductions in pre-to post-treatment and follow-up clinical outcome measures. Contrary to hypotheses, there was no clear pattern of mediating effects of RNT on clinical outcomes. Some significant mediation effects emerged: reductions in RNT mediated reductions in distress between Lesson 2 and 3 (overall and in the clinician-guided group specifically), and reductions in RNT from post-treatment to follow-up significantly mediated reductions in depression (overall). Further, in the post-treatment to follow-up period there was a significant mediating effect of rumination specifically (Brooding subscale of the RRS) on follow-up distress (overall), and in the self-help group a significant mediating effect of rumination on follow-up depression and distress. Despite these findings, a consistent pattern of mediating effects of RNT on changes in depression, anxiety and distress did not emerge across the analyses. Similarly, and as expected, the reverse pattern did not reach significance; changes in distress did not mediate changes in RNT across each lesson. The lack of consistent mediation effect of RNT contrasts with the few studies that have examined mediation in RNT-focused interventions and found that decreases in RNT did mediate treatment outcome (Topper et al., 2017; Watkins et al., 2011).
There are several possible explanations for these findings. Firstly, there may have been a lack of sufficient power to detect all mediation effects in this sample. While the power calculations informing the RCT’s target sample size were aimed at detecting a medium to large between-group effect size (Hedge’s g = 0.7) between the treatment groups and control group, based on (Topper et al. 2017; see Joubert et al., 2023), it is possible that the sample was not large enough to detect all mediation effects. Indeed Topper et al. (2017) found significant mediation effects of changes in RNT over the course of their study with a larger sample size (N = 251 vs. N = 137 in the current study), and it has been recommended that sample sizes are large in studies utilising mediation analyses (e.g., Fairchild & McDaniel, 2017). Thus it is possible that more uniform significant mediation effects may emerge when investigating the treatment in a larger sample in future studies.
Secondly, it is possible the lack of mediation findings was due to the transdiagnostic measure used in the lesson-by-lesson mediation analyses, which assessed the frequency of RNT. There may be a delineation between the mediating effect of the different sub-types of RNT, rumination and worry, as seen in the post-treatment to follow-up period (where rumination, but not worry, mediated follow-up depression and distress). This pattern gives support to the strong role of rumination on depressive symptoms (e.g., Ehring & Watkins, 2008; Nolen-Hoeksema, 2000; Nolen-Hoeksema et al., 2008). Interestingly, our analysis did not find evidence of a mediating role of reductions in RNT (transdiagnostically or by subtype) on reductions in anxiety symptoms across treatment, which contrasts with research showing that RNT plays a key causal and maintaining role in anxiety as well as depressive disorders (e.g., Ehring & Watkins, 2008; Wahl et al., 2019). Further research is needed investigating which factors mediate change in anxiety as well as depressive symptoms in RNT-focused treatment.
Similarly, it is possible that other variables not measured in this study mediated the treatment effects. Some preliminary research has found improvements in behavioural activation (Feldhaus et al., 2020), for example, may mediate change in RNT-focused treatments. This program does encourage participants to engage in behavioural activation, and schedule in distracting activities for times when they are at high risk of ruminating. Change in metacognitive beliefs about RNT (e.g., ‘ruminating helps me to solve my problems’) is a further alternative mediating variable. Some studies of one type of RNT-focused intervention, metacognitive therapy for GAD, found that reductions in negative beliefs about worry mediated reduction in worry over treatment (McEvoy et al., 2015; Wahlund et al., 2022). Another study found that participants higher in positive metacognitive beliefs about the usefulness of rumination were less likely to have positive expectations of action-oriented treatment strategies, several of which are included in the present treatment (e.g., structured problem-solving; Ophir & Mor, 2014). Other studies of transdiagnostic CBT for depression and anxiety, however, have found no significant mediation effects of either negative (Barrio-Martínez et al., 2023) or positive metacognitive beliefs (Enrique et al., 2021), so the impact of metacognitive beliefs warrants further investigation. Decentering, the metacognitive ability to appraise one’s thoughts and feelings as temporary phenomena as opposed to reality (Fresco et al., 2007), is a related variable that has been shown to reduce the link between negative or stressful events, rumination, and depressive symptoms (Feldman et al., 2010; Wu et al., 2022). While these variables were not measured in the current study, they could be measured in future studies to help elucidate alternative mediators of treatment effects beyond changes in the frequency of RNT.
The lack of a clear overall mediation pattern in this study suggests that further research is needed into which factors mediate treatment change in RNT-focused treatments such as this program. Future investigations should examine a larger sample and measure a wider range of potential mediating variables, including metacognitive beliefs about RNT and decentering, and subtypes of RNT as well as frequency. The use of moderated mediation analysis could also help understand potential interaction effects between predictor and mediating variables.

Predictors of Treatment Response

The current study is one of the first to examine predictors of treatment response in an RNT-focused intervention. Our results showed some interesting predictors of improvement—specifically, baseline severity (particularly rumination), treatment group (as a predictor of anxiety scores), and treatment expectancy—that provide some insight at the outset of the program who may benefit most.
Baseline symptom severity. In line with our hypotheses, baseline severity of outcome measures significantly predicted treatment response. In contrast to predictions however, higher baseline severity in symptoms of depression, anxiety, distress, RNT, worry and rumination, significantly predicted higher rather than lower scores in each of these outcomes following treatment. This finding is consistent with another study by Barrio-Martinez et al. (2023) in which higher baseline rumination was also associated with lower post-treatment functioning. However it contrasts with Cook et al.’s (2019) finding that participants with higher baseline stress levels demonstrated greater (preventative) benefit from RF-CBT, and another study by Niles et al. (2021) in which higher frequency of baseline negative automatic thoughts was associated with stronger improvement from general CBT treatment. In a review on predictors and moderators of treatment outcome in online psychological treatments more broadly, Haller et al. (2023) found that, similar to our study, higher baseline symptom severity predicted higher post-treatment scores; but overall, participants with higher baseline scores demonstrated greater symptom change over treatment (i.e., greater treatment benefits). It is possible that this pattern also occurred in the current intervention, as participants who received treatment on average demonstrated strong treatment benefits (gs = 0.41–0.97; Joubert et al., 2023). Future studies could examine this further by analysing the magnitude of change in participants with greater baseline severity over the course of this intervention using moderated mediation analysis.
Clinician guidance. Our results also confirm that clinician guidance predicts strong outcomes in the current treatment, particularly in post-treatment anxiety (GAD-7) scores. As shown in the RCT (Joubert et al., 2023), participants in the clinician-guided group demonstrated lower depression, anxiety and rumination scores both at post-treatment and follow-up, than the self-guided group; our analyses further show this group demonstrated larger reductions in RNT and distress lesson by lesson, and experienced reductions in RNT earlier in treatment than the self-guided group. These results are consistent with studies showing that therapist guidance and alliance is associated with stronger treatment outcomes and adherence in online treatments compared to unguided versions (Karyotaki et al., 2021; Musiat et al., 2022; Newby et al., 2024). Moderated mediation analysis in future studies could help elucidate the interaction between other predictor variables and clinician guidance, as some research shows the importance of therapist guidance relates particularly to patients with more severe baseline symptoms (e.g., Karyotaki et al., 2021; Newby et al., 2024)).
Treatment expectancy. Over and above baseline severity and treatment group, and in line with our expectations, higher treatment expectancy at baseline significantly predicted lower post-treatment depression, anxiety, RNT, rumination and worry. These findings suggest that it may be important to assess and address low treatment expectancies at treatment outset, given it is associated with clinical outcomes, and drop-out in this treatment (see Joubert et al., 2023). These findings are in line with a broader research literature showing that treatment expectancies influence the likelihood that individuals commence treatment, put effort into change, and obtain treatment benefits (Glass et al., 2001; Noble et al., 2001; Tambling, 2012), including from rumination interventions (e.g., Rebstock et al., 2020). They contrast with the recent study of group RF-CBT (Wallsten et al., 2023), but this may be explained by the smaller symptom change they found compared to the present study. Addressing negative treatment expectations may be particularly challenging however given they can be difficult to shift in depressed individuals (Everaert et al., 2018; Kube et al., 2019; Rutherford et al., 2010). Further research is needed to understand how to best alter negative expectations in RNT-focused treatments (e.g., providing reputable evidence of treatment efficacy before strategies are introduced).
Rumination. Over and above baseline severity and treatment group, higher baseline rumination also emerged as a significant predictor of higher depression, and approached significance as a predictor of higher anxiety after treatment. Changes in rumination across treatment also significantly mediated follow-up distress, as well as follow-up depression in the self-help group. These findings further support the literature showing that pre-treatment levels of rumination are predictive of outcomes in general CBT treatments for anxiety and depression (e.g., Bredemeier et al., 2020; Crane & Williams, 2010). It is possible that in this transdiagnostic RNT-focused treatment, there should be an inclusion of additional strategies, or more intensive treatment, to explicitly address rumination, in order to improve outcomes for those identified at the outset of treatment as high in this type of RNT.

Limitations

The results above should be interpreted in the context of several limitations. Due to the small sample size, there may have been a lack of power to detect statistically significant mediation. Future research should repeat mediation and predictor analyses in a larger sample. Mediation analyses in this study were limited by the variables measured in the RCT. Future studies of this and other RNT-focused interventions should measure a wider selection of potential mediating variables, such as metacognitive beliefs about RNT, decentering, behavioural activation and therapeutic alliance, or other variables not yet identified in the literature. Conclusions about the direction of the mediation effects seen in this study are also limited by the fact that the mediation and outcome variables were measured concurrently. While these results provide valuable information about the association between changes in RNT variables and outcome variables, in order for the temporal relationship of mediation to be established, future studies should include more time points across treatment to investigate true mediation effects (i.e., that changes in RNT cause changes in anxiety and depression). A further limitation relates to the generalisability of the sample. Participants were mostly female, employed, and well-educated. They were also self-selected, and partly recruited from a mailing list of previous users of the THIS WAY UP digital clinic, so may have been more likely to engage and/or had previous experience with online treatment. Future studies of the treatment in routine-care community settings are warranted to explore mediators and predictors of treatment response in more representative samples. Finally, participants were permitted to access concurrent treatment during the trial, limiting our ability to distinguish between mediators of the current treatment’s effects and other potential treatments.

Conclusion

This study is one of the first to examine the mechanisms of how an efficacious, brief, online, RNT-focused treatment works, and what factors predict treatment response. We found a gradual improvement in RNT and distress throughout treatment, with the largest reductions in RNT occurring after the lessons with the main active treatment strategies. While there was some evidence of changes in outcomes being mediated by reductions in RNT over the course of treatment, a lack of consistent mediation pattern was seen, suggesting that further research examining alternative mediating variables and across more time points is needed to clarify the processes that mediate change. Higher baseline severity of anxiety, depression and rumination predicted worse outcome, whereas clinician guidance predicted better treatment outcome. In addition to these, higher treatment expectations and baseline levels of rumination (rather than transdiagnostic RNT) most strongly predicted treatment response. Further research is needed to understand the best ways to assist those identified as likely to show a poorer response. Future studies employing larger samples will enable more comprehensive mediation and dismantling analyses, to further our understanding of the mechanisms by which this efficacious RNT intervention works.

Acknowledgements

We thank Dr Taylor Braund (Black Dog Institute, UNSW) and Elliot Dovers (Stats Central, UNSW) for their input into the statistical analyses.

Declarations

Competing interests

The authors declare no competing interests.
Informed consent was obtained from all individual participants included in the study.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijf je als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen jouw vak. Met het online abonnement heb je toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kun je op je gemak en wanneer het jou het beste uitkomt verdiepen in jouw vakgebied.

BSL Academy Accare GGZ collective

BSL GOP_opleiding GZ-psycholoog

Voetnoten
1
Program materials can be made available by contacting the corresponding author.
 
Literatuur
go back to reference American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
go back to reference Andersson, G., & Carlbring, P. (2017). Internet-assisted cognitive behavioral therapy. Psychiatric Clinics,40(4), 689–700.PubMed Andersson, G., & Carlbring, P. (2017). Internet-assisted cognitive behavioral therapy. Psychiatric Clinics,40(4), 689–700.PubMed
go back to reference Andrews, G., & Slade, T. (2001). Interpreting scores on the Kessler psychological distress scale (K10). Australian and New Zealand Journal of Public Health,25(6), 494–497.PubMedCrossRef Andrews, G., & Slade, T. (2001). Interpreting scores on the Kessler psychological distress scale (K10). Australian and New Zealand Journal of Public Health,25(6), 494–497.PubMedCrossRef
go back to reference Andrews, L. A., Hayes, A. M., Abel, A., & Kuyken, W. (2020). Sudden gains and patterns of symptom change in cognitive–behavioral therapy for treatment-resistant depression. Journal of Consulting and Clinical Psychology,88(2), 106.PubMedCrossRef Andrews, L. A., Hayes, A. M., Abel, A., & Kuyken, W. (2020). Sudden gains and patterns of symptom change in cognitive–behavioral therapy for treatment-resistant depression. Journal of Consulting and Clinical Psychology,88(2), 106.PubMedCrossRef
go back to reference Barrio-Martínez, S., Cano-Vindel, A., Priede, A., Medrano, L. A., Muñoz-Navarro, R., Moriana, J. A., Carpallo-González, M., Prieto-Vila, M., Ruiz-Rodríguez, P., & González-Blanch, C. (2023). Worry, rumination and negative metacognitive beliefs as moderators of outcomes of transdiagnostic group cognitive-behavioural therapy in emotional disorders. Journal of Affective Disorders,338, 349–357.PubMedCrossRef Barrio-Martínez, S., Cano-Vindel, A., Priede, A., Medrano, L. A., Muñoz-Navarro, R., Moriana, J. A., Carpallo-González, M., Prieto-Vila, M., Ruiz-Rodríguez, P., & González-Blanch, C. (2023). Worry, rumination and negative metacognitive beliefs as moderators of outcomes of transdiagnostic group cognitive-behavioural therapy in emotional disorders. Journal of Affective Disorders,338, 349–357.PubMedCrossRef
go back to reference Bisby, M. A., Balakumar, T., Scott, A. J., Titov, N., & Dear, B. F. (2024). An online therapist-guided ultra-brief treatment for depression and anxiety: A randomized controlled trial. Psychological Medicine,54(5), 902–913.PubMedCrossRef Bisby, M. A., Balakumar, T., Scott, A. J., Titov, N., & Dear, B. F. (2024). An online therapist-guided ultra-brief treatment for depression and anxiety: A randomized controlled trial. Psychological Medicine,54(5), 902–913.PubMedCrossRef
go back to reference Bisby, M. A., Scott, A. J., Fisher, A., Gandy, M., Hathway, T., Heriseanu, A. I., Karin, E., Cross, S., Staples, L., & Titov, N. (2023). The timing and magnitude of symptom improvements during an Internet-delivered transdiagnostic treatment program for anxiety and depression. Journal of Consulting and Clinical Psychology,91(2), 95.PubMedCrossRef Bisby, M. A., Scott, A. J., Fisher, A., Gandy, M., Hathway, T., Heriseanu, A. I., Karin, E., Cross, S., Staples, L., & Titov, N. (2023). The timing and magnitude of symptom improvements during an Internet-delivered transdiagnostic treatment program for anxiety and depression. Journal of Consulting and Clinical Psychology,91(2), 95.PubMedCrossRef
go back to reference Bredemeier, K., Lieblich, S., & Foa, E. B. (2020). Pretreatment levels of rumination predict cognitive-behavioral therapy outcomes in a transdiagnostic sample of adults with anxiety-related disorders. Journal of Anxiety Disorders,75, 102277.PubMedCrossRef Bredemeier, K., Lieblich, S., & Foa, E. B. (2020). Pretreatment levels of rumination predict cognitive-behavioral therapy outcomes in a transdiagnostic sample of adults with anxiety-related disorders. Journal of Anxiety Disorders,75, 102277.PubMedCrossRef
go back to reference Brown, T. A., Antony, M. M., & Barlow, D. H. (1992). Psychometric properties of the Penn State worry questionnaire in a clinical anxiety disorders sample. Behaviour Research and Therapy,30(1), 33–37.PubMedCrossRef Brown, T. A., Antony, M. M., & Barlow, D. H. (1992). Psychometric properties of the Penn State worry questionnaire in a clinical anxiety disorders sample. Behaviour Research and Therapy,30(1), 33–37.PubMedCrossRef
go back to reference Brown, T. A., & Barlow, D. (2014). Anxiety and related disorders interview schedule for DSM-5 (ADIS-5). Oxford University Press. Brown, T. A., & Barlow, D. (2014). Anxiety and related disorders interview schedule for DSM-5 (ADIS-5). Oxford University Press.
go back to reference Cook, L., Mostazir, M., & Watkins, E. (2019). Reducing stress and preventing depression (RESPOND): Randomized controlled trial of web-based rumination-focused cognitive behavioral therapy for high-ruminating university students. Journal of Medical Internet Research,21(5), e11349.PubMedPubMedCentralCrossRef Cook, L., Mostazir, M., & Watkins, E. (2019). Reducing stress and preventing depression (RESPOND): Randomized controlled trial of web-based rumination-focused cognitive behavioral therapy for high-ruminating university students. Journal of Medical Internet Research,21(5), e11349.PubMedPubMedCentralCrossRef
go back to reference Crane, C., & Williams, J. M. G. (2010). Factors associated with attrition from mindfulness-based cognitive therapy in patients with a history of suicidal depression. Mindfulness,1, 10–20.PubMedPubMedCentralCrossRef Crane, C., & Williams, J. M. G. (2010). Factors associated with attrition from mindfulness-based cognitive therapy in patients with a history of suicidal depression. Mindfulness,1, 10–20.PubMedPubMedCentralCrossRef
go back to reference Devilly, G. J., & Borkovec, T. D. (2000). Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy and Experimental Psychiatry,31(2), 73–86.PubMedCrossRef Devilly, G. J., & Borkovec, T. D. (2000). Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy and Experimental Psychiatry,31(2), 73–86.PubMedCrossRef
go back to reference Ebert, D. D., Van Daele, T., Nordgreen, T., Karekla, M., Compare, A., Zarbo, C., Brugnera, A., Overland, S., Trebbi, G., & Jensen, K. L. (2018). Internet-and mobile-based psychological interventions: Applications, efficacy, and potential for improving mental health. European Psychologist.,23, 167–187.CrossRef Ebert, D. D., Van Daele, T., Nordgreen, T., Karekla, M., Compare, A., Zarbo, C., Brugnera, A., Overland, S., Trebbi, G., & Jensen, K. L. (2018). Internet-and mobile-based psychological interventions: Applications, efficacy, and potential for improving mental health. European Psychologist.,23, 167–187.CrossRef
go back to reference Enrique, A., Eilert, N., Wogan, R., Earley, C., Duffy, D., Palacios, J., Timulak, L., & Richards, D. (2021). Are changes in beliefs about rumination and in emotion regulation skills mediators of the effects of internet-delivered cognitive-behavioral therapy for depression and anxiety? Results from a randomized controlled trial. Cognitive Therapy and Research,45, 805–816.CrossRef Enrique, A., Eilert, N., Wogan, R., Earley, C., Duffy, D., Palacios, J., Timulak, L., & Richards, D. (2021). Are changes in beliefs about rumination and in emotion regulation skills mediators of the effects of internet-delivered cognitive-behavioral therapy for depression and anxiety? Results from a randomized controlled trial. Cognitive Therapy and Research,45, 805–816.CrossRef
go back to reference Everaert, J., Bronstein, M. V., Cannon, T. D., & Joormann, J. (2018). Looking through tinted glasses: Depression and social anxiety are related to both interpretation biases and inflexible negative interpretations. Clinical Psychological Science,6(4), 517–528.CrossRef Everaert, J., Bronstein, M. V., Cannon, T. D., & Joormann, J. (2018). Looking through tinted glasses: Depression and social anxiety are related to both interpretation biases and inflexible negative interpretations. Clinical Psychological Science,6(4), 517–528.CrossRef
go back to reference Feldhaus, C. G., Jacobs, R. H., Watkins, E. R., Peters, A. T., Bessette, K. L., & Langenecker, S. A. (2020). Rumination-focused cognitive behavioral therapy decreases anxiety and increases behavioral activation among remitted adolescents. Journal of Child and Family Studies,29, 1982–1991.PubMedPubMedCentralCrossRef Feldhaus, C. G., Jacobs, R. H., Watkins, E. R., Peters, A. T., Bessette, K. L., & Langenecker, S. A. (2020). Rumination-focused cognitive behavioral therapy decreases anxiety and increases behavioral activation among remitted adolescents. Journal of Child and Family Studies,29, 1982–1991.PubMedPubMedCentralCrossRef
go back to reference Feldman, G., Greeson, J., & Senville, J. (2010). Differential effects of mindful breathing, progressive muscle relaxation, and loving-kindness meditation on decentering and negative reactions to repetitive thoughts. Behaviour Research and Therapy,48(10), 1002–1011.PubMedPubMedCentralCrossRef Feldman, G., Greeson, J., & Senville, J. (2010). Differential effects of mindful breathing, progressive muscle relaxation, and loving-kindness meditation on decentering and negative reactions to repetitive thoughts. Behaviour Research and Therapy,48(10), 1002–1011.PubMedPubMedCentralCrossRef
go back to reference Fresco, D. M., Moore, M. T., van Dulmen, M. H., Segal, Z. V., Ma, S. H., Teasdale, J. D., & Williams, J. M. G. (2007). Initial psychometric properties of the experiences questionnaire: Validation of a self-report measure of decentering. Behavior Therapy,38(3), 234–246.PubMedCrossRef Fresco, D. M., Moore, M. T., van Dulmen, M. H., Segal, Z. V., Ma, S. H., Teasdale, J. D., & Williams, J. M. G. (2007). Initial psychometric properties of the experiences questionnaire: Validation of a self-report measure of decentering. Behavior Therapy,38(3), 234–246.PubMedCrossRef
go back to reference Glass, C. R., Arnkoff, D. B., & Shapiro, S. J. (2001). Expectations and preferences. Psychotherapy: Theory, Research, Practice, Training,38(4), 455.CrossRef Glass, C. R., Arnkoff, D. B., & Shapiro, S. J. (2001). Expectations and preferences. Psychotherapy: Theory, Research, Practice, Training,38(4), 455.CrossRef
go back to reference Griffith, J. W., & Raes, F. (2014). Factor structure of the ruminative responses scale. European Journal of Psychological Assessment. Griffith, J. W., & Raes, F. (2014). Factor structure of the ruminative responses scale. European Journal of Psychological Assessment.
go back to reference Haller, K., Becker, P., Niemeyer, H., & Boettcher, J. (2023). Who benefits from guided internet-based interventions? A systematic review of predictors and moderators of treatment outcome. Internet Interventions,33, 100635.PubMedPubMedCentralCrossRef Haller, K., Becker, P., Niemeyer, H., & Boettcher, J. (2023). Who benefits from guided internet-based interventions? A systematic review of predictors and moderators of treatment outcome. Internet Interventions,33, 100635.PubMedPubMedCentralCrossRef
go back to reference Hvenegaard, M., Moeller, S. B., Poulsen, S., Gondan, M., Grafton, B., Austin, S. F., Kistrup, M., Rosenberg, N. G., Howard, H., & Watkins, E. R. (2020). Group rumination-focused cognitive-behavioural therapy (CBT) v. group CBT for depression: Phase II trial. Psychological Medicine,50(1), 11–19.PubMedCrossRef Hvenegaard, M., Moeller, S. B., Poulsen, S., Gondan, M., Grafton, B., Austin, S. F., Kistrup, M., Rosenberg, N. G., Howard, H., & Watkins, E. R. (2020). Group rumination-focused cognitive-behavioural therapy (CBT) v. group CBT for depression: Phase II trial. Psychological Medicine,50(1), 11–19.PubMedCrossRef
go back to reference Joubert, A. E., Grierson, A. B., Chen, A. Z., Moulds, M. L., Werner-Seidler, A., Mahoney, A. E., & Newby, J. M. (2021). Managing rumination and worry: A pilot study of an internet intervention targeting repetitive negative thinking in Australian adults. Journal of Affective Disorders,294, 483–490.PubMedCrossRef Joubert, A. E., Grierson, A. B., Chen, A. Z., Moulds, M. L., Werner-Seidler, A., Mahoney, A. E., & Newby, J. M. (2021). Managing rumination and worry: A pilot study of an internet intervention targeting repetitive negative thinking in Australian adults. Journal of Affective Disorders,294, 483–490.PubMedCrossRef
go back to reference Joubert, A. E., Grierson, A. B., Li, I., Sharrock, M. J., Moulds, M. L., Werner-Seidler, A., Stech, E. P., Mahoney, A. E., & Newby, J. M. (2023). Managing rumination and worry: A randomised controlled trial of an internet intervention targeting repetitive negative thinking delivered with and without clinician guidance. Behaviour Research and Therapy,168, 104378.PubMedCrossRef Joubert, A. E., Grierson, A. B., Li, I., Sharrock, M. J., Moulds, M. L., Werner-Seidler, A., Stech, E. P., Mahoney, A. E., & Newby, J. M. (2023). Managing rumination and worry: A randomised controlled trial of an internet intervention targeting repetitive negative thinking delivered with and without clinician guidance. Behaviour Research and Therapy,168, 104378.PubMedCrossRef
go back to reference Joubert, A. E., Moulds, M. L., Werner-Seidler, A., Sharrock, M., Popovic, B., & Newby, J. M. (2022). Understanding the experience of rumination and worry: A descriptive qualitative survey study. British Journal of Clinical Psychology,61(4), 929–946.PubMedCrossRef Joubert, A. E., Moulds, M. L., Werner-Seidler, A., Sharrock, M., Popovic, B., & Newby, J. M. (2022). Understanding the experience of rumination and worry: A descriptive qualitative survey study. British Journal of Clinical Psychology,61(4), 929–946.PubMedCrossRef
go back to reference Karyotaki, E., Efthimiou, O., Miguel, C., Genannt Bermpohl, F. M., Furukawa, T. A., Cuijpers, P., Riper, H., Patel, V., Mira, A., & Gemmil, A. W. (2021). Internet-based cognitive behavioral therapy for depression: A systematic review and individual patient data network meta-analysis. JAMA Psychiatry,78(4), 361–371.PubMedCrossRef Karyotaki, E., Efthimiou, O., Miguel, C., Genannt Bermpohl, F. M., Furukawa, T. A., Cuijpers, P., Riper, H., Patel, V., Mira, A., & Gemmil, A. W. (2021). Internet-based cognitive behavioral therapy for depression: A systematic review and individual patient data network meta-analysis. JAMA Psychiatry,78(4), 361–371.PubMedCrossRef
go back to reference Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., Normand, S.-L., Walters, E. E., & Zaslavsky, A. M. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine,32(6), 959–976.PubMedCrossRef Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., Normand, S.-L., Walters, E. E., & Zaslavsky, A. M. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine,32(6), 959–976.PubMedCrossRef
go back to reference Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001b). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.PubMedPubMedCentralCrossRef Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001b). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.PubMedPubMedCentralCrossRef
go back to reference Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016). Patient health questionnaire anxiety and depression scale: Initial validation in three clinical trials. Psychosomatic Medicine,78(6), 716–727.PubMedPubMedCentralCrossRef Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016). Patient health questionnaire anxiety and depression scale: Initial validation in three clinical trials. Psychosomatic Medicine,78(6), 716–727.PubMedPubMedCentralCrossRef
go back to reference Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care,46(3), 266–274.PubMedCrossRef Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care,46(3), 266–274.PubMedCrossRef
go back to reference Mahoney, A. E., McEvoy, P. M., & Moulds, M. L. (2012). Psychometric properties of the repetitive thinking questionnaire in a clinical sample. Journal of Anxiety Disorders,26(2), 359–367.PubMedCrossRef Mahoney, A. E., McEvoy, P. M., & Moulds, M. L. (2012). Psychometric properties of the repetitive thinking questionnaire in a clinical sample. Journal of Anxiety Disorders,26(2), 359–367.PubMedCrossRef
go back to reference McEvoy, P. M., Erceg-Hurn, D. M., Anderson, R. A., Campbell, B. N., Swan, A., Saulsman, L. M., Summers, M., & Nathan, P. R. (2015). Group metacognitive therapy for repetitive negative thinking in primary and non-primary generalized anxiety disorder: An effectiveness trial. Journal of Affective Disorders,175, 124–132.PubMedCrossRef McEvoy, P. M., Erceg-Hurn, D. M., Anderson, R. A., Campbell, B. N., Swan, A., Saulsman, L. M., Summers, M., & Nathan, P. R. (2015). Group metacognitive therapy for repetitive negative thinking in primary and non-primary generalized anxiety disorder: An effectiveness trial. Journal of Affective Disorders,175, 124–132.PubMedCrossRef
go back to reference McEvoy, P. M., Hyett, M. P., Ehring, T., Johnson, S. L., Samtani, S., Anderson, R., & Moulds, M. L. (2018). Transdiagnostic assessment of repetitive negative thinking and responses to positive affect: Structure and predictive utility for depression, anxiety, and mania symptoms. Journal of Affective Disorders,232, 375–384.PubMedCrossRef McEvoy, P. M., Hyett, M. P., Ehring, T., Johnson, S. L., Samtani, S., Anderson, R., & Moulds, M. L. (2018). Transdiagnostic assessment of repetitive negative thinking and responses to positive affect: Structure and predictive utility for depression, anxiety, and mania symptoms. Journal of Affective Disorders,232, 375–384.PubMedCrossRef
go back to reference McEvoy, P. M., Thibodeau, M. A., & Asmundson, G. J. (2014). Trait repetitive negative thinking: A brief transdiagnostic assessment. Journal of Experimental Psychopathology,5(3), 1–17.CrossRef McEvoy, P. M., Thibodeau, M. A., & Asmundson, G. J. (2014). Trait repetitive negative thinking: A brief transdiagnostic assessment. Journal of Experimental Psychopathology,5(3), 1–17.CrossRef
go back to reference Merson, F., Newby, J., Shires, A., Millard, M., & Mahoney, A. (2021). The temporal stability of the Kessler psychological distress scale. Australian Psychologist,56(1), 38–45.CrossRef Merson, F., Newby, J., Shires, A., Millard, M., & Mahoney, A. (2021). The temporal stability of the Kessler psychological distress scale. Australian Psychologist,56(1), 38–45.CrossRef
go back to reference Musiat, P., Johnson, C., Atkinson, M., Wilksch, S., & Wade, T. (2022). Impact of guidance on intervention adherence in computerised interventions for mental health problems: A meta-analysis. Psychological Medicine,52(2), 229–240.PubMedCrossRef Musiat, P., Johnson, C., Atkinson, M., Wilksch, S., & Wade, T. (2022). Impact of guidance on intervention adherence in computerised interventions for mental health problems: A meta-analysis. Psychological Medicine,52(2), 229–240.PubMedCrossRef
go back to reference Niles, A. N., Axelsson, E., Andersson, E., Hedman-Lagerlöf, E., Carlbring, P., Andersson, G., Johansson, R., Widén, S., Driessen, J., Santoft, F., & Ljótsson, B. (2021). Internet-based cognitive behavior therapy for depression, social anxiety disorder, and panic disorder: Effectiveness and predictors of response in a teaching clinic. Behaviour Research and Therapy,136, 103767. https://doi.org/10.1016/j.brat.2020.103767CrossRefPubMed Niles, A. N., Axelsson, E., Andersson, E., Hedman-Lagerlöf, E., Carlbring, P., Andersson, G., Johansson, R., Widén, S., Driessen, J., Santoft, F., & Ljótsson, B. (2021). Internet-based cognitive behavior therapy for depression, social anxiety disorder, and panic disorder: Effectiveness and predictors of response in a teaching clinic. Behaviour Research and Therapy,136, 103767. https://​doi.​org/​10.​1016/​j.​brat.​2020.​103767CrossRefPubMed
go back to reference Noble, L. M., Douglas, B. C., & Newman, S. P. (2001). What do patients expect of psychiatric services? A systematic and critical review of empirical studies. Social Science & Medicine,52(7), 985–998.CrossRef Noble, L. M., Douglas, B. C., & Newman, S. P. (2001). What do patients expect of psychiatric services? A systematic and critical review of empirical studies. Social Science & Medicine,52(7), 985–998.CrossRef
go back to reference Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology,109(3), 504.PubMedCrossRef Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology,109(3), 504.PubMedCrossRef
go back to reference Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008). Rethinking rumination. Perspectives on Psychological Science,3(5), 400–424.PubMedCrossRef Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008). Rethinking rumination. Perspectives on Psychological Science,3(5), 400–424.PubMedCrossRef
go back to reference Ophir, Y., & Mor, N. (2014). If I only knew why: The relationship between brooding, beliefs about rumination, and perceptions of treatments. Behavior Therapy,45(4), 553–563.PubMedCrossRef Ophir, Y., & Mor, N. (2014). If I only knew why: The relationship between brooding, beliefs about rumination, and perceptions of treatments. Behavior Therapy,45(4), 553–563.PubMedCrossRef
go back to reference Patel, A., Daros, A. R., Irwin, S. H., Lau, P., Hope, I. M., Perkovic, S. J. M., Laposa, J. M., Husain, M. I., Levitan, R. D., Kloiber, S., & Quilty, L. C. (2023). Associations between rumination, depression, and distress tolerance during CBT treatment for depression in a tertiary care setting. Journal of Affective Disorders,339, 74–81. https://doi.org/10.1016/j.jad.2023.06.063CrossRefPubMed Patel, A., Daros, A. R., Irwin, S. H., Lau, P., Hope, I. M., Perkovic, S. J. M., Laposa, J. M., Husain, M. I., Levitan, R. D., Kloiber, S., & Quilty, L. C. (2023). Associations between rumination, depression, and distress tolerance during CBT treatment for depression in a tertiary care setting. Journal of Affective Disorders,339, 74–81. https://​doi.​org/​10.​1016/​j.​jad.​2023.​06.​063CrossRefPubMed
go back to reference Plummer, F., Manea, L., Trepel, D., & McMillan, D. (2016). Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. General Hospital Psychiatry,39, 24–31.PubMedCrossRef Plummer, F., Manea, L., Trepel, D., & McMillan, D. (2016). Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. General Hospital Psychiatry,39, 24–31.PubMedCrossRef
go back to reference Rebstock, L., Schäfer, L. N., Kube, T., Ehmke, V., & Rief, W. (2020). Placebo prevents rumination: An experimental study. Journal of Affective Disorders,274, 1152–1160.PubMedCrossRef Rebstock, L., Schäfer, L. N., Kube, T., Ehmke, V., & Rief, W. (2020). Placebo prevents rumination: An experimental study. Journal of Affective Disorders,274, 1152–1160.PubMedCrossRef
go back to reference Reins, J. A., Buntrock, C., Zimmermann, J., Grund, S., Harrer, M., Lehr, D., Baumeister, H., Weisel, K., Domhardt, M., Imamura, K., Kawakami, N., Spek, V., Nobis, S., Snoek, F., Cuijpers, P., Klein, J. P., Moritz, S., & Ebert, D. D. (2021). Efficacy and moderators of internet-based interventions in adults with subthreshold depression: An individual participant data meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics,90(2), 94–106. https://doi.org/10.1159/000507819CrossRefPubMed Reins, J. A., Buntrock, C., Zimmermann, J., Grund, S., Harrer, M., Lehr, D., Baumeister, H., Weisel, K., Domhardt, M., Imamura, K., Kawakami, N., Spek, V., Nobis, S., Snoek, F., Cuijpers, P., Klein, J. P., Moritz, S., & Ebert, D. D. (2021). Efficacy and moderators of internet-based interventions in adults with subthreshold depression: An individual participant data meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics,90(2), 94–106. https://​doi.​org/​10.​1159/​000507819CrossRefPubMed
go back to reference Robinson, L., Delgadillo, J., & Kellett, S. (2020). The dose-response effect in routinely delivered psychological therapies: A systematic review. Psychotherapy Research,30(1), 79–96.PubMedCrossRef Robinson, L., Delgadillo, J., & Kellett, S. (2020). The dose-response effect in routinely delivered psychological therapies: A systematic review. Psychotherapy Research,30(1), 79–96.PubMedCrossRef
go back to reference Ruiz, F. J., Luciano, C., Flórez, C. L., Suárez-Falcón, J. C., & Cardona-Betancourt, V. (2020). A multiple-baseline evaluation of acceptance and commitment therapy focused on repetitive negative thinking for comorbid generalized anxiety disorder and depression. Frontiers in Psychology,11, 356.PubMedPubMedCentralCrossRef Ruiz, F. J., Luciano, C., Flórez, C. L., Suárez-Falcón, J. C., & Cardona-Betancourt, V. (2020). A multiple-baseline evaluation of acceptance and commitment therapy focused on repetitive negative thinking for comorbid generalized anxiety disorder and depression. Frontiers in Psychology,11, 356.PubMedPubMedCentralCrossRef
go back to reference Rutherford, B. R., Wager, T. D., & Roose, S. P. (2010). Expectancy and the treatment of depression: A review of experimental methodology and effects on patient outcome. Current Psychiatry Reviews,6(1), 1–10.PubMedPubMedCentralCrossRef Rutherford, B. R., Wager, T. D., & Roose, S. P. (2010). Expectancy and the treatment of depression: A review of experimental methodology and effects on patient outcome. Current Psychiatry Reviews,6(1), 1–10.PubMedPubMedCentralCrossRef
go back to reference Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., & Aravkin, A. Y. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet,398(10312), 1700–1712.CrossRef Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., & Aravkin, A. Y. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet,398(10312), 1700–1712.CrossRef
go back to reference Schmaling, K. B., Dimidjian, S., Katon, W., & Sullivan, M. (2002). Response styles among patients with minor depression and dysthymia in primary care. Journal of Abnormal Psychology,111(2), 350–356.PubMedCrossRef Schmaling, K. B., Dimidjian, S., Katon, W., & Sullivan, M. (2002). Response styles among patients with minor depression and dysthymia in primary care. Journal of Abnormal Psychology,111(2), 350–356.PubMedCrossRef
go back to reference Schoofs, H., Hermans, D., & Raes, F. (2010). Brooding and reflection as subtypes of rumination: Evidence from confirmatory factor analysis in nonclinical samples using the Dutch Ruminative Response Scale. Journal of Psychopathology and Behavioral Assessment,32, 609–617.CrossRef Schoofs, H., Hermans, D., & Raes, F. (2010). Brooding and reflection as subtypes of rumination: Evidence from confirmatory factor analysis in nonclinical samples using the Dutch Ruminative Response Scale. Journal of Psychopathology and Behavioral Assessment,32, 609–617.CrossRef
go back to reference Segal, Z., Williams, M., & Teasdale, J. (2018). Mindfulness-based cognitive therapy for depression. Guilford Publications. Segal, Z., Williams, M., & Teasdale, J. (2018). Mindfulness-based cognitive therapy for depression. Guilford Publications.
go back to reference Skelton, M., Carr, E., Buckman, J. E. J., Davies, M. R., Goldsmith, K. A., Hirsch, C. R., Peel, A. J., Rayner, C., Rimes, K. A., Saunders, R., Wingrove, J., Breen, G., & Eley, T. C. (2023). Trajectories of depression and anxiety symptom severity during psychological therapy for common mental health problems. Psychological Medicine,53(13), 6183–6193. https://doi.org/10.1017/s0033291722003403CrossRefPubMed Skelton, M., Carr, E., Buckman, J. E. J., Davies, M. R., Goldsmith, K. A., Hirsch, C. R., Peel, A. J., Rayner, C., Rimes, K. A., Saunders, R., Wingrove, J., Breen, G., & Eley, T. C. (2023). Trajectories of depression and anxiety symptom severity during psychological therapy for common mental health problems. Psychological Medicine,53(13), 6183–6193. https://​doi.​org/​10.​1017/​s003329172200340​3CrossRefPubMed
go back to reference Titov, N., Dear, B. F., McMillan, D., Anderson, T., Zou, J., & Sunderland, M. (2011). Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression. Cognitive Behaviour Therapy,40(2), 126–136.PubMedCrossRef Titov, N., Dear, B. F., McMillan, D., Anderson, T., Zou, J., & Sunderland, M. (2011). Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression. Cognitive Behaviour Therapy,40(2), 126–136.PubMedCrossRef
go back to reference Valencia, P. D., & Paredes-Angeles, R. (2022). Revisiting the factor structure of the ruminative response scale: A bifactor approach. Trends in Psychology,32, 1408–1425.CrossRef Valencia, P. D., & Paredes-Angeles, R. (2022). Revisiting the factor structure of the ruminative response scale: A bifactor approach. Trends in Psychology,32, 1408–1425.CrossRef
go back to reference Van Rijsoort, S., Emmelkamp, P., & Vervaeke, G. (1999). The Penn state worry questionnaire and the worry domains questionnaire: Structure, reliability and validity. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice,6(4), 297–307.CrossRef Van Rijsoort, S., Emmelkamp, P., & Vervaeke, G. (1999). The Penn state worry questionnaire and the worry domains questionnaire: Structure, reliability and validity. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice,6(4), 297–307.CrossRef
go back to reference Wahl, K., Ehring, T., Kley, H., Lieb, R., Meyer, A., Kordon, A., Heinzel, C. V., Mazanec, M., & Schönfeld, S. (2019). Is repetitive negative thinking a transdiagnostic process? A comparison of key processes of RNT in depression, generalized anxiety disorder, obsessive-compulsive disorder, and community controls. Journal of Behavior Therapy and Experimental Psychiatry,64, 45–53. https://doi.org/10.1016/j.jbtep.2019.02.006CrossRefPubMed Wahl, K., Ehring, T., Kley, H., Lieb, R., Meyer, A., Kordon, A., Heinzel, C. V., Mazanec, M., & Schönfeld, S. (2019). Is repetitive negative thinking a transdiagnostic process? A comparison of key processes of RNT in depression, generalized anxiety disorder, obsessive-compulsive disorder, and community controls. Journal of Behavior Therapy and Experimental Psychiatry,64, 45–53. https://​doi.​org/​10.​1016/​j.​jbtep.​2019.​02.​006CrossRefPubMed
go back to reference Wahlund, T., Hesser, H., Perrin, S., Johansson, S., Huhn, V., Sörhus, S., Lindskog, S., Serlachius, E., Hedman-Lagerlöf, E., & Ljótsson, B. (2022). Therapist-guided online metacognitive intervention for excessive worry: A randomized controlled trial with mediation analysis. Cognitive Behaviour Therapy,51(1), 21–41.PubMedCrossRef Wahlund, T., Hesser, H., Perrin, S., Johansson, S., Huhn, V., Sörhus, S., Lindskog, S., Serlachius, E., Hedman-Lagerlöf, E., & Ljótsson, B. (2022). Therapist-guided online metacognitive intervention for excessive worry: A randomized controlled trial with mediation analysis. Cognitive Behaviour Therapy,51(1), 21–41.PubMedCrossRef
go back to reference Wallsten, D., Norell, A., Anniko, M., Eriksson, O., Lamourín, V., Halldin, I., Kindbom, T., Hesser, H., Watkins, E., & Tillfors, M. (2023). Treatment of worry and comorbid symptoms within depression, anxiety, and insomnia with a group-based rumination-focused cognitive-behaviour therapy in a primary health care setting: A randomised controlled trial. Frontiers in Psychology,14, 1196945.PubMedPubMedCentralCrossRef Wallsten, D., Norell, A., Anniko, M., Eriksson, O., Lamourín, V., Halldin, I., Kindbom, T., Hesser, H., Watkins, E., & Tillfors, M. (2023). Treatment of worry and comorbid symptoms within depression, anxiety, and insomnia with a group-based rumination-focused cognitive-behaviour therapy in a primary health care setting: A randomised controlled trial. Frontiers in Psychology,14, 1196945.PubMedPubMedCentralCrossRef
go back to reference Watkins, E. R. (2009). Depressive rumination: investigating mechanisms to improve cognitive behavioural treatments. Cognitive Behaviour Therapy,38(Supp1), 8–14.PubMedPubMedCentralCrossRef Watkins, E. R. (2009). Depressive rumination: investigating mechanisms to improve cognitive behavioural treatments. Cognitive Behaviour Therapy,38(Supp1), 8–14.PubMedPubMedCentralCrossRef
go back to reference Watkins, E. R. (2018). Rumination-focused cognitive-behavioral therapy for depression. Guilford Publications. Watkins, E. R. (2018). Rumination-focused cognitive-behavioral therapy for depression. Guilford Publications.
go back to reference Watkins, E. (2022). Worry and Rumination. Oxford research encyclopedia of psychology. Oxford University Press. Watkins, E. (2022). Worry and Rumination. Oxford research encyclopedia of psychology. Oxford University Press.
go back to reference Watkins, E., Newbold, A., Tester-Jones, M., Collins, L. M., & Mostazir, M. (2023). Investigation of active ingredients within internet-delivered cognitive behavioral therapy for depression: A randomized optimization trial. JAMA Psychiatry,80(9), 942–951.PubMedPubMedCentralCrossRef Watkins, E., Newbold, A., Tester-Jones, M., Collins, L. M., & Mostazir, M. (2023). Investigation of active ingredients within internet-delivered cognitive behavioral therapy for depression: A randomized optimization trial. JAMA Psychiatry,80(9), 942–951.PubMedPubMedCentralCrossRef
go back to reference Wu, J. L., Hamilton, J. L., Fresco, D. M., Alloy, L. B., & Stange, J. P. (2022). Decentering predicts attenuated perseverative thought and internalizing symptoms following stress exposure: A multi-level, multi-wave study. Behaviour Research and Therapy,152, 104017.PubMedCrossRef Wu, J. L., Hamilton, J. L., Fresco, D. M., Alloy, L. B., & Stange, J. P. (2022). Decentering predicts attenuated perseverative thought and internalizing symptoms following stress exposure: A multi-level, multi-wave study. Behaviour Research and Therapy,152, 104017.PubMedCrossRef
go back to reference Zlomke, K. R. (2009). Psychometric properties of internet administered versions of Penn state worry questionnaire (PSWQ) and depression, anxiety, and stress scale (DASS). Computers in Human Behavior,25(4), 841–843.CrossRef Zlomke, K. R. (2009). Psychometric properties of internet administered versions of Penn state worry questionnaire (PSWQ) and depression, anxiety, and stress scale (DASS). Computers in Human Behavior,25(4), 841–843.CrossRef
Metagegevens
Titel
Mediators and Predictors of Treatment Response in a Brief Online Intervention for Rumination and Worry
Auteurs
Emily Upton
Venkatesha Venkatesha
Amy E. Joubert
Alison E. J. Mahoney
Michelle L. Moulds
Aliza Werner-Seidler
Jill M. Newby
Publicatiedatum
17-03-2025
Uitgeverij
Springer US
Gepubliceerd in
Cognitive Therapy and Research
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI
https://doi.org/10.1007/s10608-025-10593-2